Istanbul, Turkey, 15th September 2009 – Further evidence of the superior antidepressant efficacy of Valdoxan®/Thymanax® (agomelatine) over conventional selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenalin reuptake inhibitor (SNRI) antidepressants was presented today at the Servier satellite symposium on the occasion of the 22nd European College of Neuropsychopharmacology (ECNP) Congress, with educational financial support provided [...]

The number of web sites selling prescriptions drugs without proper authorization is increasing. Because these sales are not regulated, the safety and authenticity of their medicines cannot be guaranteed. Servier, out of concern for the health and well-being of its patients, opposes the unauthorized or illegal sale and importation of drugs via the internet. Patients [...]

Welcome to the www.valdoxan.com website.
By using this site you acknowledge having read the legal notice and you undertake to comply with it. The content of this document may undergo changes; consequently we invite you to consult the legal notice regularly.
1. Legal notice
This site is owned by LES LABORATOIRES SERVIER, a company with a share capital [...]

Valdoxan 25 mg film-coated tablets
Agomelatine
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, [...]

Servier
The Servier’s corporate website.

Dialogues in Clinical Neuroscience
The electronic version of the Dialogues in Clinical Neuroscience journal.

Medicographia
The electronic version or The Medicographia journal.

1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
[...]